308 related articles for article (PubMed ID: 23190500)
1. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.
Alimova I; Birks DK; Harris PS; Knipstein JA; Venkataraman S; Marquez VE; Foreman NK; Vibhakar R
Neuro Oncol; 2013 Feb; 15(2):149-60. PubMed ID: 23190500
[TBL] [Abstract][Full Text] [Related]
2. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
[TBL] [Abstract][Full Text] [Related]
4. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
6. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
[TBL] [Abstract][Full Text] [Related]
7. Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors.
Alimova I; Wang D; Danis E; Pierce A; Donson A; Serkova N; Madhavan K; Lakshmanachetty S; Balakrishnan I; Foreman NK; Mitra S; Venkataraman S; Vibhakar R
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35179215
[TBL] [Abstract][Full Text] [Related]
8. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
Kemp CD; Rao M; Xi S; Inchauste S; Mani H; Fetsch P; Filie A; Zhang M; Hong JA; Walker RL; Zhu YJ; Ripley RT; Mathur A; Liu F; Yang M; Meltzer PA; Marquez VE; De Rienzo A; Bueno R; Schrump DS
Clin Cancer Res; 2012 Jan; 18(1):77-90. PubMed ID: 22028491
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
10. PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.
Sato T; Kaneda A; Tsuji S; Isagawa T; Yamamoto S; Fujita T; Yamanaka R; Tanaka Y; Nukiwa T; Marquez VE; Ishikawa Y; Ichinose M; Aburatani H
Sci Rep; 2013; 3():1911. PubMed ID: 23714854
[TBL] [Abstract][Full Text] [Related]
11. Targeting the enhancer of zeste homologue 2 in medulloblastoma.
Alimova I; Venkataraman S; Harris P; Marquez VE; Northcott PA; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
Int J Cancer; 2012 Oct; 131(8):1800-9. PubMed ID: 22287205
[TBL] [Abstract][Full Text] [Related]
12. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
13. Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer.
Ishikawa S; Hayashi H; Kinoshita K; Abe M; Kuroki H; Tokunaga R; Tomiyasu S; Tanaka H; Sugita H; Arita T; Yagi Y; Watanabe M; Hirota M; Baba H
Int J Cancer; 2014 Dec; 135(11):2528-36. PubMed ID: 24346863
[TBL] [Abstract][Full Text] [Related]
14. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
15. Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.
Venkataraman S; Alimova I; Tello T; Harris PS; Knipstein JA; Donson AM; Foreman NK; Liu AK; Vibhakar R
J Neurooncol; 2012 May; 107(3):517-26. PubMed ID: 22246202
[TBL] [Abstract][Full Text] [Related]
16. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
Zhou W; Wang J; Man WY; Zhang QW; Xu WG
Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
[TBL] [Abstract][Full Text] [Related]
17. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.
Zhou J; Bi C; Cheong LL; Mahara S; Liu SC; Tay KG; Koh TL; Yu Q; Chng WJ
Blood; 2011 Sep; 118(10):2830-9. PubMed ID: 21734239
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.
Kao CL; Huang PI; Tsai PH; Tsai ML; Lo JF; Lee YY; Chen YJ; Chen YW; Chiou SH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):219-28. PubMed ID: 19362240
[TBL] [Abstract][Full Text] [Related]
19. OTX2 Defines a Subgroup of Atypical Teratoid Rhabdoid Tumors With Close Relationship to Choroid Plexus Tumors.
Japp AS; Klein-Hitpass L; Denkhaus D; Pietsch T
J Neuropathol Exp Neurol; 2017 Jan; 76(1):32-38. PubMed ID: 28025236
[TBL] [Abstract][Full Text] [Related]
20. Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
Bai J; Ma M; Cai M; Xu F; Chen J; Wang G; Shuai X; Tao K
Cell Prolif; 2014 Jun; 47(3):211-8. PubMed ID: 24738879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
